Claros Diagnostics Raises $4 Million

Claros Diagnostics Inc., a Woburn, Mass.-based developer of handheld urological cancer diagnostic testing systems for point-of-care use, has raised $4 million in second-round funding, according to a regulatory filing. Shareholders include Oxford Bioscience Partners, Bioventures Investors, Accelerated Technologies Partners and Commons Capital. www.clarosdx.com

Related Posts

Leave a Reply

PEHUB Community

Join the 12494 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget

Groups